IBAB reports H1 2026 revenue and margin growth
IBAB said H1 2026 revenue and margin grew, citing robust proton therapy orders and reaffirmed guidance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
IBAB reports strong H1 2026 with 6% revenue growth
IBAB said H1 2026 revenue rose 6% with improved margins and robust order intake.